Patricia L. Mottram - Concepedia

Author

Patricia L. Mottram

Also Known As

Mottram P, Mottram, P.L., P L Mottram, P MOTTRAM, P Mottram, P. L MOTTRAM, P. L. MOTTRAM, P. L. Mottram, P. MOTTRAM, P. Mottram

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

The Royal Melbourne Hospital The University of Melbourne Walter and Eliza Hall Institute of Medical Research Austin Hospital Burnet Institute

About

Patricia L. Mottram is an author at The Royal Melbourne Hospital specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1.2K
2	Allergy	9	9	656
3	Engineering	1	1	103
4	Natural Sciences	1	1	42
5	Biomedical Engineering	1	1	103

Patricia L. Mottram

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors Theodora Fifis, Anita Gamvrellis, Blessing Crimeen‐Irwin, The Journal of Immunology	2004	661
The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement Irina Caminschi, Anna I. Proietto, Fatma Ahmet, Blood	2008	465
Type 1 and 2 Immunity Following Vaccination Is Influenced by Nanoparticle Size: Formulation of a Model Vaccine for Respiratory Syncytial Virus Patricia L. Mottram, David Tai Leong, Blessing Crimeen‐Irwin, Molecular Pharmaceutics	2006	289
FcγRI-Deficient Mice Show Multiple Alterations to Inflammatory and Immune Responses Nadine Barnes, Amanda L. Gavin, Peck Szee Tan, Immunity InflammationCytokineMedicineImmunologyImmune Regulation	2002	203
Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Patricia L. Mottram, Wenruo Han, L. J. Purcell, PubMed Cell TherapyCd4+ CellsTransplantation MedicineImmunologyCell Replacement Therapy	1995	170
INCREASED EXPRESSION OF IL-4 AND IL-10 AND DECREASED EXPRESSION OF IL-2 AND INTERFERON-γ IN LONG-SURVIVING MOUSE HEART ALLOGRAFTS AFTER BRIEF CD4-MONOCLONAL ANTIBODY THERAPY1,2 Patricia L. Mottram, Wenruo Han, Lisa J. Purcell, Transplantation Cell TherapyCd4+ CellsImmune RegulationImmunologyTransplantation Medicine	1995	142
Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity Martha Kalkanidis, Geoffrey A. Pietersz, Sue D. Xiang, Methods NanoparticlesNanomedicineCross-protectionVaccinationEngineering	2006	103
Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific tumour challenge in mice Theodora Fifis, Patricia L. Mottram, Violeta Bogdanoska, Vaccine Class IiCancer ImmunosurveillanceMhc ClassImmunologyTumor Immunity	2004	82
Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody‐induced inflammation in Fcγ receptor IIa–transgenic mice Caroline T. Sardjono, Patricia L. Mottram, Nicholas C. van de Velde, Arthritis & Rheumatism	2005	78
Antigen delivery via two molecules on the CD8<sup>–</sup> dendritic cell subset induces humoral immunity in the absence of conventional “danger” Alexandra J. Corbett, Irina Caminschi, Brent S. McKenzie, European Journal of Immunology Adaptive Immune SystemDc SubsetsHumoral ResponseImmunologyImmunologic Mechanism	2005	77

Page 1